S'abonner

The role of timing in the treatment of spinal cord injury - 01/07/17

Doi : 10.1016/j.biopha.2017.05.048 
Amene Saghazadeh a, b, c, Nima Rezaei b, d, e,
a Molecular Immunology Research Center, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran 
b Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran 
c MetaCognition Interest Group (MCIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran 
d Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran 
e Systematic Review and Meta-analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Boston, USA 

Corresponding author at: Children’s Medical Center Hospital, Dr Qarib St, Keshavarz Blvd, Tehran, 14194, Iran.Children’s Medical Center Hospital, Dr Qarib St, Keshavarz Blvd, Tehran, 14194Iran

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

pages 12
Iconographies 5
Vidéos 0
Autres 0

Highlights

The microenvironment of injured spinal cord substantially varies over time.
Studies suggest benefits of targeting excitotoxicity, inflammation, and neurodegeneration during first minutes, hours and weeks after SCI.
Acute inflammation initially induced by SCI tends to be permanent, even at several years after SCI.
Considering the seconds-dependent state of spinal cord after primary injury is a therapeutic and also preventive against future complications.
There is a great scarcity of clinical trials evaluating efficacy of early interventions to modulate microenvironment of the injured spinal cord.

Le texte complet de cet article est disponible en PDF.

Abstract

Regeneration failure after primary spinal cord injury (SCI) leads to diverse clinical complications in a severity- and level of SCI-dependent manner. The cost of treating both of them (initial regeneration failure and following complications) would be prohibitive, particularly in less developed nations. The well-recognized circumstances arose from primary SCI include excitotoxicity and inflammation. SCI increases concentrations of extracellular amino acids (EAAs) in the severity-dependent manner and the maximum level of EAAs at the injury site will be reduced by distance from the injury site. Increased concentrations of EAAs and their signaling result in energy and metabolic changes and eventually neurotoxicity. Therefore EAAs play a crucial role in moving towards secondary stage of SCI. There is a close correspondence between severity of SCI and intensity of acute inflammatory response, which includes proinflammatory cytokines (IL-1β, TNF-α, and IL-6) and immune cells (neutrophils, microglia, and mast cells). The communication between microglia and astrocytes mediate formation of astroglial scar. The scar is thought to diminish the spread of inflammation and lesion volume, and on the other side poses an obstacle to achieving axon regeneration. Moreover, mast cells exert an anti-inflammatory role in the ground of injured spinal cord by degradation of proinflammatory mediators, while mast cells-derived histamine may cause excitotoxicity. Therefore research suggests a very double-sword remark about the work of inflammatory mediators in the injured spinal cord. Myelin associated inhibitors (MAIs) are among the growing list of extrinsic inhibitors of neuroregeneration in the injured-CNS. They function via NgR-dependent mechanisms. The time for intervention by NgR antagonists must be fixed according to the expression pattern of this receptor and its dependent MAIs after SCI. Altogether, experimental studies suggest potential benefits of combating EAAs, inflammatory mediators, and MAIs during the first minutes, hours and weeks after SCI, respectively. However, acute inflammation initially induced by SCI tends to be permanent, even at several years after SCI. This supports the notion that paying attention to inflammation must persist through time. The consideration of seconds-dependent state of spinal cord after primary injury is a very therapeutic and also preventive approach against future possible complications. It is thereby possible to propose “timing”, which is perfectly practicable throughout the world, as an effective campaign against the final failure of SCI.

Le texte complet de cet article est disponible en PDF.

Keywords : Spinal cord injury, Regeneration, Complications, Excitotoxicity, Inflammation, Cytokines, Neurodegeneration, Timing


Plan


© 2017  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 92

P. 128-139 - août 2017 Retour au numéro
Article précédent Article précédent
  • The role of secretory phospholipases as therapeutic targets for the treatment of myocardial ischemia reperfusion injury
  • Sriram Ravindran, Gino A. Kurian
| Article suivant Article suivant
  • Antidiabetic properties of Capparis spinosa L. and its components
  • Hamideh Vahid, Hassan Rakhshandeh, Ahmad Ghorbani

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.